Keywords: amgen, kepivance, gets, nod, chmp, biotechnology, major

Amgen's Kepivance gets nod from CHMP

Article | 08 August 2005

US biotechnology major Amgen has received a positive marketing authorization opinion from the European Committee for Medicinal Products for Human ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing

Related Drugs

Nystatin

Kepivance

Palifermin

Go to drug listing